PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-03 (2)

Date Title Company
03-Oct-2023 New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO Businesswire